Sanofi Strengthens Vaccine Portfolio with $2.2B Dynavax Acquisition
Sanofi has announced it has agreed to acquire Dynavax Technologies Corporation, a publicly traded vaccines company, in a move that
Read moreSanofi has announced it has agreed to acquire Dynavax Technologies Corporation, a publicly traded vaccines company, in a move that
Read moreThe leading global biotechnology company advancing protein-based vaccines, Novavax, announced that the European Commission has granted Marketing Authorisation for the
Read moreThe GERBU Adjuvant MTM is developed specifically for monoclonal antibody production and offers a high yield of IgG and fused
Read moreGERBU offers ready-to-use adjuvants which can dramatically improve the yield of polyclonal and monoclonal antibodies. Adjuvant auxiliary drug carrier immunoadjuvant,
Read moreThe GERBU Adjuvant P TM is developed specifically for polyclonal antibody production. Containing non-hazardous immuno active components, this adjuvant is
Read moreThe GERBU Adjuvant FTM is ideal for use in vaccine development and research purposes. Powerful Immune-potentiating Adjuvant The GERBU Adjuvant
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreMerck (NYSE: MRK), known as MSD outside the United States and Canada, announced on Saturday the first results from the
Read moreGSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreBristol Myers Squibb announced positive results from a Phase 3 Trial, which showed that neoadjuvant treatment with three cycles of
Read more